IL33 and Acute hepatitis: Since repeated application of IL-33 enhances regulatory Tregs that are known regulators of liver inflammation [110], these cells are suggested to confer IL-33-mediated protection against acute hepatitis by limiting the function of pro-inflammatory cells, including ILC2s.